Searchable abstracts of presentations at key conferences in endocrinology

ea0056p650 | Endocrine tumours and neoplasia | ECE2018

Non-genomic effects of thyroid hormones on mesenchymal stem cells in tumour angiogenesis

Schmohl Kathrin A , Dohmann Maike , Schwenk Nathalie , Bartenstein Peter , Nelson Peter J , Spitzweg Christine

Tumour stroma formation is associated with angiogenesis and requires interactions of various different cell types, including endothelial cells and mesenchymal stem cells (MSCs), which are actively recruited into growing tumour stroma. Thyroid hormones T3 and T4 act as non-classical proangiogenic modulators mediated by non-genomic mechanisms via cell surface receptor integrin αvβ3. The deaminated T4 derivative tetrac is a specific inhibitor of thyroid hormone action a...

ea0041gp226 | Thyroid Cancer | ECE2016

Systemic epidermal growth factor receptor-targeted gene delivery using the theranostic sodium iodide symporter (NIS) gene in an advanced orthotopic tumor model

Urnauer Sarah , Morys Stephan , Muller Andrea M , Oos Rosel , Carlsen Janette , Bartenstein Peter , Wagner Ernst , Spitzweg Christine

The well characterized sodium iodide symporter (NIS) in its dual function as reporter and therapy gene displays an outstanding opportunity to target different cancer types allowing non-invasive imaging of functional NIS expression and therapeutic radionuclide application. We recently reported induction of tumor-selective accumulation and therapeutic efficacy of radioiodide after systemic non-viral epidermal growth factor receptor (EGFR)-targeted NIS gene delivery in a subcutan...

ea0041ep1098 | Thyroid cancer | ECE2016

Sequence defined cMET/HGFR-targeted polymers as gene delivery vehicles for the theranostic sodium iodide symporter (NIS) gene

Urnauer Sarah , Morys Stephan , Levacic Ana Krhac , Muller Andrea M , Schug Christina , Schmohl Kathrin A , Schwenk Nathalie , Zach Christian , Carlsen Janette , Bartenstein Peter , Wagner Ernst , Spitzweg Christine

The sodium iodide symporter (NIS) in its role as well characterized reporter and therapy gene represents an outstanding tool to target different cancer types allowing non-invasive imaging of functional NIS expression by 123I-scintigraphy and therapeutic application of 131I. Based on its overexpression on the surface of the vast majority of cancer types, the cMET/Hepatocyte growth factor receptor (HGFR) serves as an ideal target for tumor-selective gene de...